Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis: Viewpoint

Tropical Medicine and International Health

Volumn 15, Issue 6, 2010, Pages 659-663

  Harries, Anthony D ^a,b,q   Murray, Megan B ^c,d   Jeon, Christie Y ^c   Ottmani, Salah Eddine ^e   Lonnroth, Knut ^e   Barreto, Mauricio L ^f   Billo, Nils ^a   Brostrom, Richard ^g   Bygbjerg, Ib Christian ^h   Fisher Hoch, Susan ⁱ   Mori, Toru ^j   Ramaiya, Kaushik ^k,l   Roglic, Gojka ^e   Strandgaard, Hanne ^m   Unwin, Nigel ⁿ   Viswanathan, Vijay ^o   Whiting, David ^p   Kapur, Anil ^m  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

^b LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

^c HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^d BRIGHAM AND WOMEN S HOSPITAL   (United States)

^e WORLD HEALTH ORGANIZATION   (Switzerland)

^f FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^g CNMI Division of Public Health   (Spain)

^h UNIVERSITY OF COPENHAGEN   (Denmark)

ⁱ UNIVERSITY OF TEXAS   (United States)

^j RESEARCH INSTITUTE OF TUBERCULOSIS   (Japan)

^k Shree Hindu Mandal Hospital   (Tanzania)

^l MUHIMBILI UNIVERSITY OF HEALTH AND ALLIED SCIENCES   (Tanzania)

^m World Diabetes Foundation   (Denmark)

ⁿ NEWCASTLE UNIVERSITY   (United Kingdom)

^o MV Hospital for Diabetes   (India)

^p International Diabetes Federation   (Belgium)

^q Old Inn Cottage   (United Kingdom)

more..

Author keywords

Diabetes mellitus; Research; Screening; Treatment outcomes; Tuberculosis

Indexed keywords

GLUCOSE; HEMOGLOBIN A1C; ISONIAZID; ORAL ANTIDIABETIC AGENT; RIFAMPICIN; TUBERCULOSTATIC AGENT;

DIABETES; DISEASE CONTROL; DISEASE TREATMENT; PUBLIC HEALTH; RESEARCH; TUBERCULOSIS;

CHEMOPROPHYLAXIS; DEATH; DIABETES CONTROL; DIABETES MELLITUS; DRUG EFFICACY; EVIDENCE BASED MEDICINE; GLUCOSE BLOOD LEVEL; HEALTH EDUCATION; HUMAN; HYPERGLYCEMIA; MASS SCREENING; MEDICAL RESEARCH; MYCOBACTERIUM TUBERCULOSIS; POINT OF CARE TESTING; PREVALENCE; REVIEW; SHORT COURSE THERAPY; SPUTUM CULTURE; TREATMENT OUTCOME; TUBERCULOSIS; TUBERCULOSIS CONTROL;

DIABETES COMPLICATIONS; DIABETES MELLITUS; HEALTH SERVICES RESEARCH; HUMANS; MASS SCREENING; PROGRAM DEVELOPMENT; TREATMENT OUTCOME; TUBERCULOSIS;

AFRICA;

EID: 77952269576     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2010.02523.x     Document Type: Review

References (17)

1. De Cock KM Odhiambo J (2006) HIV testing in patients with TB. Tropical Doctor 36, 71 73.
2. Dooley KE Chaisson RE (2009) Tuberculosis and diabetes mellitus: convergence of two epidemics. The Lancet Infectious Diseases 9, 737 746.
3. Drabo KM, Dauby C, Cost T et al. (2006) Decentralising tuberculosis case management in two districts of Burkina Faso. The International Journal of Tuberculosis and Lung Disease 10, 93 98.
4. Edginton ME (1990) Tuberculosis patient care decentralised to district clinics with community-based directly observed treatment in a rural district of South Africa. The International Journal of Tuberculosis and Lung Disease 3, 445 450.
5. Harries AD, Jahn A, Zachariah R Enarson D (2008) Adapting the DOTS framework for tuberculosis control to the management of non-communicable diseases in sub-Saharan Africa. PLoS Medicine 5, e124.
6. Harries AD, Zachariah R, Kapur A, Jahn A Enarson DA (2009) The vital signs of chronic disease management. Transactions of the Royal Society of Tropical Medicine and Hygiene 103, 537 540.
7. Havlir D, Getahun H, Sanne I Nunn P (2008) Opportunities and challenges for HIV care in overlapping HIV and TB epidemics. JAMA 300, 423 430.
8. International Diabetes Federation (2009) IDF Diabetes Atlas. 4th edn. International Diabetes Federation
9. Jeon CY Murray MB (2008) Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies. PLoS Medicine 5, e152.
10. Kranzer K, Houben RMGJ, Glynn JR, Bekker LG, Wood R Lawn SD (2010) Yield of HIV-associated tuberculosis during intensified case finding in resource-limited settings: a systematic review and meta-analysis. The Lancet Infectious Diseases 10, 93 102.
11. Lesnichii AV Karpina LZ (1969) [Experience with the chemoprophylaxis of pulmonary tuberculosis in diabetes mellitus patients]. Problemy Tuberkuleza 47, 1 3.
12. Pfaffenberg R Jahler H (1958) [Isoniazid and recurrence of tuberculosis in diabetics]. Zeitschrift für Tuberkulose 111, 167 173.
13. Smart T (2009) Catalyzing HIVTB research: a meeting report. HATiP: Issue 47, 15 October, 2 8.
14. Stevenson CR, Critchley JA, Forouhi NG et al. (2007a) Diabetes and the risk of tuberculosis: a neglected threat to public health. Chronic Illness 3, 228 245.
15. Stevenson CR, Forouhi NG, Roglic G et al. (2007b) Diabetes and tuberculosis: the impact of the diabetes epidemic on tuberculosis incidence. BMC Public Health 7, 234.
16. World Health Organization (2006) The Global Plan to Stop TB 2006-2015. WHO
17. World Health Organization (2009) Global Tuberculosis Control 2009. Epidemiology, Strategy, Financing. WHO